[HTML][HTML] Recent Insights into Particulate Matter (PM2.5)-Mediated Toxicity in Humans: An Overview

P Thangavel, D Park, YC Lee - International journal of environmental …, 2022 - mdpi.com
Several epidemiologic and toxicological studies have commonly viewed ambient fine
particulate matter (PM2. 5), defined as particles having an aerodynamic diameter of less …

[HTML][HTML] Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling …

D Adeloye, P Song, Y Zhu, H Campbell… - The Lancet …, 2022 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is an increasingly important
cause of morbidity, disability, and mortality worldwide. We aimed to estimate global …

[HTML][HTML] The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

AA Voors, CE Angermann, JR Teerlink, SP Collins… - Nature medicine, 2022 - nature.com
The sodium–glucose cotransporter 2 inhibitor empagliflozin reduces the risk of
cardiovascular death or heart failure hospitalization in patients with chronic heart failure, but …

[HTML][HTML] The sirtuin family in health and disease

QJ Wu, TN Zhang, HH Chen, XF Yu, JL Lv… - … and Targeted Therapy, 2022 - nature.com
Sirtuins (SIRTs) are nicotine adenine dinucleotide (+)-dependent histone deacetylases
regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in …

[HTML][HTML] Neutrophils in chronic inflammatory diseases

A Herrero-Cervera, O Soehnlein… - Cellular & molecular …, 2022 - nature.com
Chronic inflammation is a component of many disease conditions that affect a large group of
individuals worldwide. Chronic inflammation is characterized by persistent, low-grade …

Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment

IA Yang, CR Jenkins, SS Salvi - The Lancet Respiratory Medicine, 2022 - thelancet.com
Chronic obstructive pulmonary disease (COPD) was traditionally thought to be caused by
tobacco smoking. However, recognition of the importance of non-smoking-related risk …

Epidemiology of cardiovascular disease in Europe

N Townsend, D Kazakiewicz, F Lucy Wright… - Nature Reviews …, 2022 - nature.com
This Review presents data describing the health burden of cardiovascular disease (CVD)
within and across the WHO European Region. CVD remains the most common cause of …

[HTML][HTML] Polypill strategy in secondary cardiovascular prevention

JM Castellano, SJ Pocock, DL Bhatt… - … England Journal of …, 2022 - Mass Medical Soc
Background A polypill that includes key medications associated with improved outcomes
(aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as …

Association of habitual alcohol intake with risk of cardiovascular disease

KJ Biddinger, CA Emdin, ME Haas, M Wang… - JAMA network …, 2022 - jamanetwork.com
Importance Observational studies have consistently proposed cardiovascular benefits
associated with light alcohol consumption, while recent genetic analyses (ie, mendelian …

[HTML][HTML] Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision

B Celli, L Fabbri, G Criner, FJ Martinez… - American journal of …, 2022 - atsjournals.org
Attempts to define concepts and things date back to the time of Aristotle, around 2,400 years
ago, when he proposed that a definition should state the essential nature or being of …